Origami Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Investors
  • 14

Origami Therapeutics General Information

Description

Developer of next-generation disease-modifying protein degraders and correctors designed to treat neurodegenerative diseases. The company offers selective protein degradation and small molecule treatments, enabling patients suffering from Alzheimer's, Huntington's, Parkinson's, ALS, and Frontotemporal Dementia to benefit from targeted and efficient therapies.

Contact Information

Website
www.origamitherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9276 Scranton Road
  • Suite 200
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 9276 Scranton Road
  • Suite 200
  • San Diego, CA 92121
  • United States

Origami Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Origami Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC (Series A) Upcoming Pre-Clinical Trials
14. Seed Round 08-Apr-2026 In Progress Product Development
13. Equity Crowdfunding 14-Mar-2026 Completed Product Development
12. Grant 29-Aug-2025 Completed Pre-Clinical Trials
11. Angel (individual) 28-Jun-2024 Completed Pre-Clinical Trials
10. Grant 01-Jan-2023 Completed Product Development
9. Accelerator/Incubator 01-Jan-2023 Completed Product Development
8. Later Stage VC 26-Apr-2022 Completed Product Development
7. Accelerator/Incubator 29-Mar-2022 $500K $500K Completed Product Development
6. Accelerator/Incubator 04-May-2021 Completed Product Development
To view Origami Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Origami Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Origami Therapeutics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual)
National Institutes of Neurological Disorders and Stroke Government
NuFund Venture Group Angel Group Minority
California Life Sciences Accelerator/Incubator
U.S. Department of Health and Human Services Government
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Origami Therapeutics FAQs

  • When was Origami Therapeutics founded?

    Origami Therapeutics was founded in 2015.

  • Where is Origami Therapeutics headquartered?

    Origami Therapeutics is headquartered in San Diego, CA.

  • What is the size of Origami Therapeutics?

    Origami Therapeutics has 7 total employees.

  • What industry is Origami Therapeutics in?

    Origami Therapeutics’s primary industry is Drug Discovery.

  • Is Origami Therapeutics a private or public company?

    Origami Therapeutics is a Private company.

  • What is Origami Therapeutics’s current revenue?

    The current revenue for Origami Therapeutics is .

  • How much funding has Origami Therapeutics raised over time?

    Origami Therapeutics has raised $1.64M.

  • Who are Origami Therapeutics’s investors?

    , National Institutes of Neurological Disorders and Stroke, NuFund Venture Group, California Life Sciences, and U.S. Department of Health and Human Services are 5 of 14 investors who have invested in Origami Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process